Vanda Pharmaceuticals Inc
Analysts review Vanda Pharmaceuticals Inc’s rating
Vanda Pharmaceuticals Inc’s recently made public that its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $41500.0 ...
Vanda Pharmaceuticals Inc [VNDA] Investment Guide: What You Need to Know
In a filing, Vanda Pharmaceuticals Inc revealed its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $41500.0 ...
Recent Insider Activity Suggests Potential Gains for Vanda Pharmaceuticals Inc (VNDA)
Vanda Pharmaceuticals Inc’s filing revealed that its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $41500.0 on ...
Vanda Pharmaceuticals Inc (VNDA) receives a Buy rating from B. Riley Securities
Vanda Pharmaceuticals Inc’s recent filing unveils that its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $41500.0 ...
A Guide To The Risks Of Investing In Vanda Pharmaceuticals Inc (VNDA)
In a filing, Vanda Pharmaceuticals Inc revealed its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $41500.0 ...
